Kashiv BioSciences

Since its establishment in 2011, Kashiv BioSciences has grown into a top-tier, fully integrated biopharmaceutical company, offering next-generation drug delivery technologies, biosimilars, and specialty biopharmaceutical products. Patient-centered, Kashiv BioSciences leverages its expertise in small and large molecules to develop a pipeline of clinically differentiated new compounds and biosimilars, with leading candidates across various therapeutic areas including CNS, endocrinology, oncology, and several debilitating orphan diseases. Kashiv BioSciences plans to commercialize its products through strategic partnerships and specific products by building an internal dedicated sales and marketing organization.